Arena Pharmaceuticals, Inc.

Press Releases



All Releases

View Summary Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin
Feb 1, 2012
PDF 12.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces $33 Million Financing
Jan 11, 2012
PDF 7.5 KB Add to Briefcase
View Summary FDA Accepts Resubmission of Lorcaserin New Drug Application
Jan 10, 2012
PDF 12.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Jan 5, 2012
PDF 9.8 KB Add to Briefcase
View Summary Arena Submits Response to FDA Complete Response Letter for Lorcaserin
Jan 3, 2012
PDF 16.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
Dec 8, 2011
PDF 9.3 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference
Nov 23, 2011
PDF 9.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
Nov 9, 2011
PDF 21.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, November 10
Nov 3, 2011
PDF 9.7 KB Add to Briefcase
View Summary New Data Analyses from Lorcaserin Phase 3 Clinical Trials to be Presented at Obesity 2011
Sep 26, 2011
PDF 14.8 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
Sep 21, 2011
PDF 9.2 KB Add to Briefcase
View Summary Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
Aug 12, 2011
PDF 9.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
Aug 9, 2011
PDF 19.0 KB Add to Briefcase
View Summary Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
Aug 9, 2011
PDF 16.2 KB Add to Briefcase
View Summary Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
Aug 2, 2011
PDF 14.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
Aug 1, 2011
PDF 9.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
Jul 12, 2011
PDF 10.6 KB Add to Briefcase
View Summary Lorcaserin Data to be Presented at the American Diabetes Association's 71st Scientific Sessions
Jun 20, 2011
PDF 14.6 KB Add to Briefcase
View Summary Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals' Lorcaserin Achieved Statistically Significant Weight Loss
May 26, 2011
PDF 13.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals' Lorcaserin to be Featured in Presentations at 18th European Congress on Obesity
May 20, 2011
PDF 11.6 KB Add to Briefcase
Showing 81-100 of 452 Page: 1 2 3 4 5 6 7 8 9 ... 23  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase